Acute promyelocytic leukemia developed in a patient with congenital antithrombin III deficiency

Takanori Moriki, Mitsuru Murata, Masahiro Kizaki, Yohko Kawai, Kiyoaki Watanabe, Yasuo Ikeda

Research output: Contribution to journalArticle

Abstract

A case of acute promyelocytic leukemia (APL) developed in a patient with congenital antithrombin III (AT-III) deficiency is reported. Despite the presence of disseminated intravascular coagulation (DIC), plasma AT-111 activity was not decreased at the diagnosis of APL compared to the patient's baseline level (∼ 50% of normal). He was successfully treated with all-trans retinoic acid (ATRA) to achieve complete remission without the use of heparin. Although he developed phlebitis at the site of insertion of the intravenous catheter during remission-induction, no major thrombotic episode was noted. Coagulation parameters including fibrin and fibrinogen degradation products (FDP-E), thrombin-antithrombin complex (TAT), FDP-D dimer (D-D dimer), and plasmin-α2 plasmin inhibitor complex (PIC) improved rapidly after initiation of ATRA. This case is a clear demonstration of the characteristics of DIC developing in APL, i.e. no or minimal decrease in the level of AT-III activity and a predominant increase in the fibrinolytic system, rather than hypercoagulability.

Original languageEnglish
Pages (from-to)39-42
Number of pages4
JournalInternational Journal of Hematology
Volume61
Issue number1
Publication statusPublished - 1995 Jan

Fingerprint

Antithrombin III Deficiency
Acute Promyelocytic Leukemia
Disseminated Intravascular Coagulation
Tretinoin
Fibrin Fibrinogen Degradation Products
Remission Induction
Phlebitis
Thrombophilia
Antithrombin III
Heparin
Catheters
formycin diphosphate
fibrin fragment D

Keywords

  • Acute promyelocytic leukemia
  • All-trans retinoic acid
  • Antithrombin III deficiency
  • Disseminated intravascular coagulation

ASJC Scopus subject areas

  • Hematology

Cite this

Acute promyelocytic leukemia developed in a patient with congenital antithrombin III deficiency. / Moriki, Takanori; Murata, Mitsuru; Kizaki, Masahiro; Kawai, Yohko; Watanabe, Kiyoaki; Ikeda, Yasuo.

In: International Journal of Hematology, Vol. 61, No. 1, 01.1995, p. 39-42.

Research output: Contribution to journalArticle

Moriki, Takanori ; Murata, Mitsuru ; Kizaki, Masahiro ; Kawai, Yohko ; Watanabe, Kiyoaki ; Ikeda, Yasuo. / Acute promyelocytic leukemia developed in a patient with congenital antithrombin III deficiency. In: International Journal of Hematology. 1995 ; Vol. 61, No. 1. pp. 39-42.
@article{f8c8de057616415f8eb157a0da3f0773,
title = "Acute promyelocytic leukemia developed in a patient with congenital antithrombin III deficiency",
abstract = "A case of acute promyelocytic leukemia (APL) developed in a patient with congenital antithrombin III (AT-III) deficiency is reported. Despite the presence of disseminated intravascular coagulation (DIC), plasma AT-111 activity was not decreased at the diagnosis of APL compared to the patient's baseline level (∼ 50{\%} of normal). He was successfully treated with all-trans retinoic acid (ATRA) to achieve complete remission without the use of heparin. Although he developed phlebitis at the site of insertion of the intravenous catheter during remission-induction, no major thrombotic episode was noted. Coagulation parameters including fibrin and fibrinogen degradation products (FDP-E), thrombin-antithrombin complex (TAT), FDP-D dimer (D-D dimer), and plasmin-α2 plasmin inhibitor complex (PIC) improved rapidly after initiation of ATRA. This case is a clear demonstration of the characteristics of DIC developing in APL, i.e. no or minimal decrease in the level of AT-III activity and a predominant increase in the fibrinolytic system, rather than hypercoagulability.",
keywords = "Acute promyelocytic leukemia, All-trans retinoic acid, Antithrombin III deficiency, Disseminated intravascular coagulation",
author = "Takanori Moriki and Mitsuru Murata and Masahiro Kizaki and Yohko Kawai and Kiyoaki Watanabe and Yasuo Ikeda",
year = "1995",
month = "1",
language = "English",
volume = "61",
pages = "39--42",
journal = "International Journal of Hematology",
issn = "0925-5710",
publisher = "Springer Japan",
number = "1",

}

TY - JOUR

T1 - Acute promyelocytic leukemia developed in a patient with congenital antithrombin III deficiency

AU - Moriki, Takanori

AU - Murata, Mitsuru

AU - Kizaki, Masahiro

AU - Kawai, Yohko

AU - Watanabe, Kiyoaki

AU - Ikeda, Yasuo

PY - 1995/1

Y1 - 1995/1

N2 - A case of acute promyelocytic leukemia (APL) developed in a patient with congenital antithrombin III (AT-III) deficiency is reported. Despite the presence of disseminated intravascular coagulation (DIC), plasma AT-111 activity was not decreased at the diagnosis of APL compared to the patient's baseline level (∼ 50% of normal). He was successfully treated with all-trans retinoic acid (ATRA) to achieve complete remission without the use of heparin. Although he developed phlebitis at the site of insertion of the intravenous catheter during remission-induction, no major thrombotic episode was noted. Coagulation parameters including fibrin and fibrinogen degradation products (FDP-E), thrombin-antithrombin complex (TAT), FDP-D dimer (D-D dimer), and plasmin-α2 plasmin inhibitor complex (PIC) improved rapidly after initiation of ATRA. This case is a clear demonstration of the characteristics of DIC developing in APL, i.e. no or minimal decrease in the level of AT-III activity and a predominant increase in the fibrinolytic system, rather than hypercoagulability.

AB - A case of acute promyelocytic leukemia (APL) developed in a patient with congenital antithrombin III (AT-III) deficiency is reported. Despite the presence of disseminated intravascular coagulation (DIC), plasma AT-111 activity was not decreased at the diagnosis of APL compared to the patient's baseline level (∼ 50% of normal). He was successfully treated with all-trans retinoic acid (ATRA) to achieve complete remission without the use of heparin. Although he developed phlebitis at the site of insertion of the intravenous catheter during remission-induction, no major thrombotic episode was noted. Coagulation parameters including fibrin and fibrinogen degradation products (FDP-E), thrombin-antithrombin complex (TAT), FDP-D dimer (D-D dimer), and plasmin-α2 plasmin inhibitor complex (PIC) improved rapidly after initiation of ATRA. This case is a clear demonstration of the characteristics of DIC developing in APL, i.e. no or minimal decrease in the level of AT-III activity and a predominant increase in the fibrinolytic system, rather than hypercoagulability.

KW - Acute promyelocytic leukemia

KW - All-trans retinoic acid

KW - Antithrombin III deficiency

KW - Disseminated intravascular coagulation

UR - http://www.scopus.com/inward/record.url?scp=0028799757&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028799757&partnerID=8YFLogxK

M3 - Article

C2 - 7718768

AN - SCOPUS:0028799757

VL - 61

SP - 39

EP - 42

JO - International Journal of Hematology

JF - International Journal of Hematology

SN - 0925-5710

IS - 1

ER -